169 related articles for article (PubMed ID: 21521860)
1. Generic substitution of levetiracetam resulting in increased incidence of breakthrough seizures.
Fitzgerald CL; Jacobson MP
Ann Pharmacother; 2011 May; 45(5):e27. PubMed ID: 21521860
[TBL] [Abstract][Full Text] [Related]
2. Seizure risk in brain tumor patients with conversion to generic levetiracetam.
Armstrong TS; Choi S; Walker J; Gilbert MR
J Neurooncol; 2010 May; 98(1):137-41. PubMed ID: 19936624
[TBL] [Abstract][Full Text] [Related]
3. Brand name to generic substitution of levetiracetam in patients with epilepsy.
Gha-Hyun L; Dae SJ
Seizure; 2018 Aug; 60():127-131. PubMed ID: 29960217
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with generic levetiracetam in people with epilepsy.
Chaluvadi S; Chiang S; Tran L; Goldsmith CE; Friedman DE
Epilepsia; 2011 Apr; 52(4):810-5. PubMed ID: 21426334
[TBL] [Abstract][Full Text] [Related]
5. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN
Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with poor seizure control and increased side effects after switching to generic antiepileptic drugs.
Bautista RE; Gonzales W; Jain D
Epilepsy Res; 2011 Jun; 95(1-2):158-67. PubMed ID: 21530177
[TBL] [Abstract][Full Text] [Related]
7. Impact of generic substitution on levetiracetam serum concentration-A prospective study in an outpatient setting.
Reimers A; Olsson P; Nilsson J; Hoff E; Reis M; Strandberg M; Lundgren A; Källén K
Epilepsy Res; 2017 Aug; 134():54-61. PubMed ID: 28595756
[TBL] [Abstract][Full Text] [Related]
8. Acceptability and tolerability of levetiracetam oral solution for the treatment of partial-onset seizures: the SOLUCIÓN study.
Matías-Guíu J; Molins A; Mauri JA; Villar E
Methods Find Exp Clin Pharmacol; 2010 Sep; 32(7):507-16. PubMed ID: 21069102
[TBL] [Abstract][Full Text] [Related]
9. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
[TBL] [Abstract][Full Text] [Related]
10. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
Friedman D; French JA
Neurology; 2006 Feb; 66(4):590-1. PubMed ID: 16505320
[TBL] [Abstract][Full Text] [Related]
11. Nonepileptic seizures under levetiracetam therapy.
Ignatenco A; Arzy S; Ghika J; Genoud D; Kaplan PW; Groppa S; Seeck M
Epilepsy Behav; 2010 Nov; 19(3):526-7. PubMed ID: 20934390
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis.
Chatterjee A; Louis ED; Frucht S
Mov Disord; 2002 May; 17(3):614-5. PubMed ID: 12112221
[TBL] [Abstract][Full Text] [Related]
13. Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy.
Freitas-Lima P; Alexandre V; Pereira LR; Feletti F; Perucca E; Sakamoto AC
Epilepsy Res; 2011 Mar; 94(1-2):117-20. PubMed ID: 21282041
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacology and clinical results of levetiracetam (E Keppra(®) Tablets), a new antiepileptic drug].
Ishii Y; Tanaka T
Nihon Yakurigaku Zasshi; 2011 Feb; 137(2):95-102. PubMed ID: 21321459
[No Abstract] [Full Text] [Related]
15. Are generic drugs really inferior medicines?
Moore N; Berdaï D; Bégaud B
Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
[TBL] [Abstract][Full Text] [Related]
16. Quality of life after switching to generic levetiracetam - A prospective comparative study.
Olsson P; Reimers A; Källén K
Epilepsy Behav; 2019 Jul; 96():169-174. PubMed ID: 31150996
[TBL] [Abstract][Full Text] [Related]
17. Treatment with levetiracetam in a patient with pervasive developmental disorders, severe intellectual disability, self-injurious behavior, and seizures: a case report.
Deriaz N; Willi JP; Orihuela-Flores M; Galli Carminati G; Ratib O
Neurocase; 2012; 18(5):386-91. PubMed ID: 22059937
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam: preliminary efficacy in generalized seizures.
Kasteleijn-Nolst Trenité DG; Hirsch E
Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes associated with brand-to-generic phenytoin interchange.
Kinikar SA; Delate T; Menaker-Wiener CM; Bentley WH
Ann Pharmacother; 2012 May; 46(5):650-8. PubMed ID: 22550275
[TBL] [Abstract][Full Text] [Related]
20. Remember Keppra: seizure control with subcutaneous levetiracetam infusion.
Murray-Brown FL; Stewart A
BMJ Support Palliat Care; 2016 Mar; 6(1):12-3. PubMed ID: 26811092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
